| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.044 | 0.7 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |